Jason Haddock

Insider Reports History

Entity
Individual
Location
C/O Array Biopharma Inc., 3200 Walnut St, Boulder, CO
Signature
/s/ Peter Silverman as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason Haddock:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Merus N.V. Director Share Option (right to buy) 17.7K $239K $13.52 May 7, 2024 Direct
Codiak BioSciences, Inc. Director Common Stock 8.75K Feb 16, 2023 Direct
Codiak BioSciences, Inc. Director Stock Option (Right to Buy) 7.5K Jun 17, 2022 Direct
Codiak BioSciences, Inc. Director Restricted Stock Units 0 Feb 16, 2023 Direct

Insider Reports Filed by Jason Haddock

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MRUS Merus N.V. May 7, 2024 1 $0 4 May 9, 2024 Director
MRUS Merus N.V. May 7, 2024 0 $0 3 May 9, 2024 Director
CDAKQ Codiak BioSciences, Inc. Feb 16, 2023 2 $0 4 Feb 21, 2023 Director
CDAKQ Codiak BioSciences, Inc. Jun 17, 2022 2 $0 4 Jun 21, 2022 Director
CDAKQ Codiak BioSciences, Inc. Feb 16, 2022 1 $0 4 Feb 18, 2022 Director
CDAKQ Codiak BioSciences, Inc. Jun 18, 2021 1 $0 4 Jun 22, 2021 Director